Campaigners Threaten Legal Action Over NHS Drug Price Deal

Two campaign groups are threatening to sue the UK government unless it scraps a key element of its drug pricing agreement with the Trump administration, arguing that changes to how NHS treatments get approved amount to an unlawful transfer of power. The concern is that the new approval process could leave the NHS paying even higher prices for medicines than it already does.